Novo A/S is the holding company of the Novo Group, wholly-owned by the Novo Nordisk Foundation.
Novo A/S is the majority shareholder in the publicly listed companies Novo Nordisk A/S and Novozymes A/S
Novo A/S’ objective is to manage the Foundation’s financial assets through investments in the life science area and in a broad portfolio of financial assets.
Read more
|
/Anual_Report.jpg)
DK UK |
